title: Effects of rocuronium and vecuronium on initial rundown of endplate potentials in the isolated phrenic nerve diaphragm preparation of rats.
abstract: Rocuronium and vecuronium, two non-depolarizing neuromuscular blockers, have been widely used in surgery procedures. However, their electrophysiological properties need to be more widely explored. We examined the effects of rocuronium and vecuronium on initial rundown of endplate potential amplitudes in the non-uniform stretched muscle preparation of the rat isolated phrenic nerve diaphragm. More specifically, the endplate potentials were recorded with one microelectrode from a single endplate. The effects of rocuronium or vecuronium each at 4 concentrations (0.5 ×, l ×, 2 ×, 4 × EC95; EC95 = concentration of the drug required to produce the inhibitory effect by 95%) on the amplitude of endplate potentials and its rundown were observed. Treatment of the isolated rat phrenic nerve-diaphragm preparation with rocuronium (2.5-20 μg/ml) or vecuronium (0.5-4 μg/ml) decreased the amplitude of endplate potentials and inhibited its rundown in a concentration-dependent manner. At the concentration (2.5 μg/ml for rocuronium and 0.5 μg/ml for vecuronium) that did not alter the endplate potential amplitude, the onset of reduced endplate potential rundown was 3 and 5 min after administration of rocuronium or vecuronium, respectively. The results suggest that rocuronium and vecuronium block the neuromuscular junction presynaptically and that rocuronium does it faster than vecuronium.
authors: Department of Anesthesiology, Navy General Hospital of PLA, Beijing, 100037 China.
authors: Jun
authors: J
authors: Li
authors: Yong-Qin
authors: YQ
authors: Liu
authors: Han-Ting
authors: HT
authors: Zhang
keywords: Diaphragm; Motor endplate; Neuromuscular junction; Rocuronium; Vecuronium
references: Springerplus. 2013 Apr 11;2(1):155
references: 23641322
references: Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):125-30
references: 16445711
references: Can J Anaesth. 1992 Sep;39(7):665-9
references: 1394754
references: Br J Pharmacol. 1997 Feb;120(4 Suppl):3-26; discussion 1-2
references: 9142393
references: J Neurophysiol. 1999 Dec;82(6):3030-40
references: 10601438
references: Anesth Analg. 1980 Dec;59(12):935-43
references: 6255826
references: Eur J Anaesthesiol. 1996 Jul;13(4):385-8
references: 8842662
references: J Clin Anesth. 1998 Aug;10(5):410-5
references: 9702623
references: Anesthesiology. 1991 Aug;75(2):191-6
references: 1859007
references: J Anaesthesiol Clin Pharmacol. 2010 Oct;26(4):493-7
references: 21547177
references: Muscle Nerve. 2009 Jul;40(1):139-42
references: 19533664
references: Anesth Analg. 2002 Jul;95(1):109-13, table of contents
references: 12088952
references: Trends Pharmacol Sci. 1989 Mar;10(3):110-4
references: 2574510
references: Br J Anaesth. 2009 Jul;103(1):108-14
references: 19546202
references: Acta Anaesthesiol Scand. 1994 Aug;38(6):535-41
references: 7976141
references: Eur J Anaesthesiol Suppl. 1995 Sep;11:15-7
references: 8556999
references: Pharmacol Toxicol. 1994 Jan;74(1):3-9
references: 8159634
references: Anesthesiology. 1985 Apr;62(4):388-91
references: 2858993
references: Anesthesiology. 1988 Jul;69(1):57-62
references: 2898902